5 completed, 2 recruiting. 7 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Recruiting 2 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Active Treatment: new trials by email Literature Review of Active Treatment trials Research Report on Active Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain Active Treatment, Non-active Treatment - Pain, Nerve | Phase 2 / Phase 3 | Recruiting | Stanford University | 95 | 2024-11-01 | 2026-04-24 |
| Chinese Medicine for Treating Chronic Pharyngolaryngitis Qingyan Lihou Decoction, Placebo - Chronic Pharyngolaryngitis (Disorder) | Phase 2 | Recruiting | Chinese University of Hong Kong | 74 | 2023-03-30 | 2026-07-30 |
| Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients Sulfasalazine, Placebos - Breast Cancer, Chronic Pain Due to Malignancy (Finding) | Phase 2 | Completed | University of Arizona | 7 | 2021-05-03 | 2025-01-09 |
| Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants Ibuprofen oral suspension, Placebo - Patent Ductus Arteriosus After Premature Birth, Patent Ductus Arteriosus Conservative Management | Phase 2 | Completed | Nada Youssef | 80 | 2021-04-15 | 2023-02-28 |
| Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) miconazole 2% oil, vehicle oil - Otomycosis | Phase 2 / Phase 3 | Completed | Hill Dermaceuticals, Inc. | 382 | 2020-07-08 | 2024-01-19 |
| A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes Ladarixin, Placebo - Diabetes Mellitus, Insulin-Dependent | Phase 2 | Completed | Dompé Farmaceutici S.p.A | 76 | 2016-08-01 | 2024-04-19 |
| A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia EV06 Ophthalmic Solution, Placebo Ophthalmic Solution - Presbyopia | Phase 1 / Phase 2 | Completed | Encore Vision, Inc. | 75 | 2015-09-16 | 2018-07-02 |
Breast Neoplasms (1) · Diabetes Mellitus, Type 1 (1) · Neuralgia (1) · Otomycosis (1) · Presbyopia (1) · Signs and Symptoms (1)
Chinese University of Hong Kong (1) · Dompé Farmaceutici S.p.A (1) · Encore Vision, Inc. (1) · Hill Dermaceuticals, Inc. (1) · Nada Youssef (1) · Stanford University (1) · University of Arizona (1)
United States (4) · Belgium (1) · Egypt (1) · Germany (1) · Hong Kong (1) · Italy (1)
Arnaldo Rivera, MD (1) · Brent Benscoter, MD (1) · Emanuele Bosi, MD (1) · Gary Brandt, MD (1) · Jeffrey Adelglass, MD (1) · John Ansley, MD (1) · Kenneth Hodge, MD (1) · Linda Woo, MD (1) · Mohab M Ibrahim, PhD., MD (1) · Nada H Youssef (1) · Oscar DeValle, MD (1) · Patrick Dennis, MD (1) · Quyen T Nguyen, MD (1) · Randall Ow, MD (1)
2014 (1), R21CA245411 (1)